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Abstract:   It is crucial to analyze the blood samples correctly and fast in open heart surgery. 
Because of that, the reliability of point of care testing (POCT) analysis systems is an essential 
point for the clinician. This study aimed to investigate the compatibility of the parameters 
measured with the i-STAT blood gas analyzer and the conventional blood gas analyzer Rapid 
Point 500 (Siemens Healthcare Diagnostics, USA) in patients who underwent cardiovascular 
surgery. This clinical study included fifty patients undergoing coronary artery bypass surgery. 
Fifty whole blood samples were portioned and measured on the i-STAT and RP500 laboratory 
analyzers — the compatibility between pH, pCO2, pO2, Hb, Na
+, K+, iCa 2+ and glucose values 
investigated. There was a good correlation between the i-STAT analyzer with the RP500 
analyzer, except Hb and Na+. Also, all parameters except for Hb and ionized calcium were 
found to be within acceptable range regarding clinical decision limits. It is essential that the 
point-of-care devices give accurate results as well as quick results. For this reason, we think 
that the point of care devices should be subject to external and internal quality control 
programs, users should be trained regularly, and feedback studies should be done.  
Keywords:  Blood gas analysis; Point of care testing; Hand-held portable analysis;Coronary 
artery bypass surgery; Operating room    
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INTRODUCTION 
Blood gas analysis (BGA) is one of the 
most important tests used in emergency 
services, intensive and critical care units. Short 
turn around times is known to improve clinical 
outcomes by accelerating the decision-making 
process and patient care. The need for rapid 
laboratory test results leads to improve point of 
care testing (POCT) analysis systems as they 
are easy to use and cost effective. (Jatlow P. 
2013, Parvin CA et al. 1996, Kilgore ML et al 
1999, Price CP 2002)  
Hand-held portable BGA systems are 
routinely used in some hospitals to provide 
more rapid, effective and also reliable results 
especially in critical care units (Nichols JH et 
al. 2000, Chin Pin Yeo et al. 2011, Dascombe 
BJ et al. 2007). The i-STAT (Abbott Point of 
Care, East Windsor, NJ, USA) is one of the 
portable BGA analysis systems(Chin Pin Yeo 
et al. 2011). Sediame S et al. studied 92 
routine blood gas samples of physiologically 
normal patients and found that results of i-
STAT portable devices were reliable in 
comparison to conventional laboratory blood 
gas analyzer. Jacobs E et al. evaluated the 
performance of the i-STAT Portable Clinical 
Analyzer and found that the results of operator 
technique provided reliable results. (Sediame 
S et al. 1999, Jacobs E et al. 1993).  
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To our knowledge, there are only a few 
studies performed with critically ill patients. 
Oyaert M et al. evaluated the analytical 
performance of a new cartridge type blood gas 
analyzer GEM Premier 5000 (Werfen) for pH, 
partial carbon dioxide pressure, and partial 
oxygen pressure determination. They 
emphasized that the evaluated device was 
suitable for both POCT and laboratory use 
(Oyaert M et al. 2018). 
Lewis T C et al. studied 24 blood gas 
measurements including pH, partial pressure 
of oxygen and partial pressure of carbon 
dioxide to 5043 m. The samples were analyzed 
using an Abbott i-STAT blood gas analyzer 
and G3+ cartridges. They found that it is useful 
for both research and therapeutic 
measurements in remote, rural and wilderness 
medicine (Lewis T C et al. 2018). 
 In our study, we aimed to investigate 
the compatibility of the parameters measured 
with the i-STAT blood gas analyzer and the 
conventional blood gas analyzer Rapid Point 
500 (Siemens Healthcare Diagnostics, USA) in 
patients who underwent cardiovascular 
surgery.  
 
MATERIALS AND METHODS  
 Whole blood from patients undergoing 
coronary artery bypass cases (n=50) collected 
and analyzed between January 2015 and 
January 2016. The patients were undergoing  
CABG with a beating heart or having a cardiac 
or non-cardiac simultaneous operation not 
included in this study. Fifty whole blood 
samples  were portioned and measured on the 
i-STAT and RP500 laboratory analyzers. The 
evaluation of the i-STAT and Rapidpoint 500 
laboratory analyzers were performed using 50 
randomly collected samples with PICO50 
lithium-balanced heparin whole blood syringe 
(Radiometer, Denmark) from CABG cases. 
Two simultaneous blood gas samples were 
taken from each patient at any time. Thus, a 
total of 100 samples were collected from 50 
patients.  
Patients were informed about the study 
preoperatively, and their written consent 
obtained from the volunteer patients. One of 
the samples were first analyzed using the i-
STAT in operation room, and the other sample 
was managed to reach laboratory by staff to 
perform the analyze with Rapidpoint 500 
(Siemens Healthcare Diagnostics, USA).  
This process took approximately 2–3 
min for each sample. Results of Rapidpoint 
500 determined via a calibration curve which is 
instrument-specifically generated by one-point 
(every 30 minutes) or 2-point calibration (every 
2 hours). Results of i-STAT determined after 
calibration for each sample. Precision was 
determined using internal quality control 
samples, 20 runs performed in a day in 
duplicate for within-run precision and two runs 
per day in duplicate each for 20 days 
performed for between-day precision. Two 
levels of internal quality control materials are 
used for both devices every 8 hours a day. 
The laboratory has an external quality control 
program attendance that the materials are 
studied once a month — the compatibility 
between pH, pCO2, pO2, Hb, Na
+, K+, iCa2+ 
and glucose values investigated. 
The i-STAT point-of-care laboratory 
system uses a single-use disposable cartridge 
containing chemically sensitive biosensors. 
CG8+cartridge has a biosensor that consists of 
amperometric, potentiometric and 
conductometric circuits.  The measurement of 
pH, pCO2, Na
+, K+, ionized (iCa2+) performed 
with potentiometric ion-selective electrode 
(ISE) measurement; the amperometric 
electrodes used for the measurement of pO2  
and glucose. The measurement of hematocrit 
(Hct) was performed with conductometric 
analysis.  
Hemoglobin (Hb) is automatically 
calculated using the formula: Hb (g/dL) =Hct 
(% PCV) x 0.34.i-STAT Cartridges stored in 
the refrigerator at +4°C and before use, the 
sealed packaging was opened and left in the 
room for 5 minutes. The results are available 
in 2 minutes.  
 Laboratory testing performed on the 
Rapidpoint 500 (Siemens Healthcare 
Diagnostics, USA) for blood gas and 
electrolyte measurement. RP500 blood gas 
analyzer cartridges use the potentiometric 
measurement of pH, pCO2 Na
+, K+, and iCa2+. 
The amperometric electrodes used for 
measuring pO2 and glucose. Hemoglobin (Hb) 
measured by the co-oximetry method. Rapid 
Point 500 blood gas analyzer cartridges were 
kept in the room temperature (15-30 °C) until 
use. Every sample saved until the final output. 
Both devices were kept side-by-side to 
preserve the equality of the environmental 
factors when the analysis performed.  
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For each sample, calibrations of devices, 
automatic sample integrity, and quality controls 
performed before an operation. 
 Within-day and between-day precision 
studies were performed with the RP500 
system. The i-STAT precision studies were 
calculated according to the data provided by 
the manufacturer.Duplicate measurements 
were done in method comparison studies. The 
study was approved by the Local Ethics 
Committee of Bozok University Faculty of 
Medicine and conducted according to the 
revised Declaration of Helsinki (1998).  
 The findings of this study were analyzed 
SPSS 18. The conformity of continuous 
variables to normal distribution was tested with 
the Kolmogorov–Smirnov test. The descriptive 
statistics of continuous variables were 
expressed as mean ± standard deviation for 
normal distributions. Linear regression 
analysis was performed for calculating bias 
(mean difference) and illustrated using Bland-
Altman plots with the differences in parameter 
values between the methods plotted aganist 
their means. Total allowable error (TEA) and 
desirable bias  based on within and between 
biological variations for each analytes were 
used (Ricos C et al 2014).  Mean Bias was 
assessed using the formula: mean difference
(%)=[(test tube mean-reference tube mean)/ 
reference tube mean x 100]( Ricos C, 
2014).The statistical signifiance was 
calculated using pearson’s two-tailed t-test. P-
value of <0.05 was considered statistically 
significant.Paired t-test and Wilcoxon test were 
used for parametric and nonparametric tests 
respectively:95% CI – confidence intervals of 
95%.  
 
RESULTS AND DİSCUSSİON  
The results of patient samples obtained 
from i-STAT and the reference device RP500 
were shown in Table 1. The correlation 
cofficients (R) between the i-STAT and RP500 
were >0.89 for each parameter,with the 
exception of Hb and Na+ (0.31, 0.57 
respectively).The acquired resultsof 
parameters from Bland-Altman plots of the the 
i-STAT and RP500are shown inFigure 
1.Statistically significant differences werefound 
for Hb(p=0.028),  pH, pCO2, pO2, Na
+, K+, 
Ca2+and glucose(all parameters p<0.001) 
between i-STAT and RP500. 
The between-day and within-day 
precision of RP500 were shown in Table 2 and 
Table 3. The CV %  of all parameters of 
RP500 were < 2.42 .The precision values of i-
STAT were shown in Table 4.  
The blood gas parameters showed 
significant biases for pCO2, Hb,Na
+, 
iCa2+andglucose parametres(mean bias-3.57% 
desirable bias±1.8%,mean bias14.18% 
desirable bias±1.84%,  mean bias-1.73% 
desirable bias±0.23%,mean bias-2.67% 
desirable bias±0.6%,  mean bias-2.17% 
desirable bias±1.8%) respectively (Table 1). 
Lower and upper limits of clinical 
insignificant difference calculated based on  
total allowable error (TEa) in RP500 
parameters were shown in Table 5,  i-STAT 
parameters were within the indicated limits, 
with the exception of Hb and iCa2+ (Table 5). 
In the present study, we compared the results 
of electrolytes, pH, blood gases, Hb and 
metabolites in whole blood measured bythe i-
STAT analyzer (Abbott Point of Care, East 
Windsor, NJ, USA) andconventional  
laboratoryblood gas analyzer (Rapid Point 
500, Siemens Healthcare Diagnostics, USA). 
Also our study compared the correlation 
between the i-STAT and RP500. These two 
analyzersshowedhigh correlation (R>0.89) 
except Na+ (R=0.57)  and Hb (R=0.31).  
In a study the analysers of i-STAT and 
Central Laboratory were compared and there 
were similar correlation coefficients with the 
results ofour study(Na+R=0.56)( Chin Pin Yeo 
et al 2011).These findings were in contrast to 
the previously reported excellent results 
(R=0.84–0.99) between the epocdevice and 
the i-STAT(Stotler BA,Kratz A 2013,Steinfelder
-Vischer J et al 2008,Papadea C et al 2002). In 
terms of Hb results, we found bad correlation 
(R=0.31) however other studies showed better 
correlation results (Luukkonen AA et al 
2015,Leino A, Kurvinen K 2011). 
 Although there were low data between 
two analyzers in terms of the significance of 
the mean bias, some studies detected the 
difference of bias based on the biological 
variaton database and the external quality 
control data (Luukkonen AA et al 2015). 
Significant differences in Hb, pCO2, glucose 
values were determined according to the 
desirable biological variaton database. Despite 
the absence of desirable bias , the data was 
evaluated based on the bias value from 
external quality results and a significant 
difference was detected.  
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  pH p02 pC02 Hb Na
+ K+ Ca+2 Glucose 
Unit   mmHg mmHg g/dL mmol/L mmol/L mmol/L mg/dL 
Slope# 
1,02x 
(-0,94~ 
0,53) 
1,046x 
(0,97~ 
1,11) 
1,003x 
(0,90~ 
1,10) 
0,13x 
(0,015~ 
0,25) 
0,969x 
(-48,91~ 
62,37) 
0,992x 
(0,93~ 
1,05) 
1,080x 
(0,92~ 
1,24) 
1,020x 
(0,98~ 
1,05) 
y-
intercept# 
-0,202 
(0,93~ 
1,13) 
-13,19 
(-21,93~ 
-4,45) 
1,234 
(-2,35~ 
4,81) 
9,22 
(7,58~ 
10,87) 
6,727 
(0,56~ 
1,37) 
0,014 
(-0,23~ 
0,25) 
-0,052 
(0,92~ 
1,24) 
0,340 
(-6,72~ 
7,40) 
RP500 
7,45** 
(7.22~7.60
) 
93,95** 
(29~425) 
37,25** 
(27.1~60.8
) 
10,93** 
(5.4~10.3) 
139,54±6.89
* 
4,02±0.64
* 
1,12±0.10
* 
176,98** 
(101~359) 
i-STAT 
7,44** 
(7.20~7.54
) 
102,46** 
(27.5~358.4
) 
35,92** 
(23.9~61.1
) 
12,48** 
(7.8~16.03
) 
137,12±4.05
* 
4,05±0.63
* 
1,09±0.08
* 
173,22** 
(95~348) 
Agreemen
t mean ¥ 
0,011 
(0,003~ 
0,018) 
-8,50 
(-
13,9~3,10) 
1,32 
(0,64~2) 
-1,55 
(-2,98~ 
-0,11) 
2,42 
(0,81~4,03) 
-0,02 
(-0,06~ 
-0,01) 
0,04 
(0,02~0,05
) 
3,76 
(1,25~6,26
) 
Mean Bias 
(%) 
-0,013 9,50 -3,57 14,18 -1,73 0,74 -2,67 -2,17 
Desirable 
bias (%)** 
- - ±1,8 ±1,84 ±0,23 ±1,81 ±0,6 ±1,8 
Acceptanc
e limit₸ 
±0,11 ±12,91 ±1,79 - ±0,54 ±0,66 ±2,58 ±0,07 
R 0,95 0,97 0,94 0,31 0,57 0,97 0,89 0,99 
p-value* <0,001 <0,001 <0,001 0,028 <0,001 <0,001 <0,001 <0,001 
Range of 
results 
7,20~7,60 27,5~425 23,9~61,1 5,4~16,03 128~178 2,8~5,8 0,85~1,42 95~359 
N 50 50 50 50 50 50 50 50 
*p-value was calculated by pearson’s two tailed correlation test.**Mean Bias was assessed 
using the formula: mean difference (%) = [ (test tube mean - reference tube mean) / reference 
tube mean x 100 ]. Desirable bias based on within and between biological variations (11). . 
*Mean±SD; **Median (min-max):Paired t-test and Wilcoxon test were used for parametric and 
nonparametric tests respectively:95% CI – confidence intervals of 95%. 
Table 1. Correlation statisticis between RP500 and i-STAT  
Parameter 
Level 1 
Mean 
  
SD 
  
CV% 
Level 2 
Mean 
  
SD 
  
CV% 
pH 7,12 -   7,31 -   
p02 (mmHg) 148,41 1,48 0,99 102,57 1,52 1,48 
pC02(mmHg) 69,99 1,69 2,42 42,62 0,73 1,72 
Hb(g/dL) 18,09 0,07 0,40 13,9 0,047 0,33 
Na+ (mmol/L) 118,65 0,37 0,31 142,86 0,29 0,20 
K+(mmol/L) 3,26 0,006 0,21 5,30 0,02 0,38 
iCa+2(mmol/
L) 
1,65 0,012 0,75 1,29 0,006 0,53 
Glucose(mg/
dL) 
189,6 1,26 0,66 94,4 0,84 0,89 
Table 2. Precision  for between-day  of RP500 system 
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Parameter 
  
Level 1 
Mean 
  
SD 
  
CV% 
Level 2 
Mean 
  
SD 
  
CV% 
pH 7,11 0,003 0,04 7,30 0,002 0,02 
pO2 (mmHg) 151,9 0,48 0,31 103,78 0,93 0,90 
pCO2(mmHg) 71,52 0,31 0,43 43,26 0,30 0,71 
Hb(g/dL) 18 - - 13,85 0,05 0,38 
Na+ (mmol/L) 118,5 0,2 0,16 142,09 0,15 0,17 
K+(mmol/L) 3,23 0,013 0,40 5,28 0,04 0,78 
iCa+2(mmol/
L) 
1,66 0,004 0,26 1,31 0,004 0,78 
Glucose(mg/
dL) 
191,2 1,78 0,93 94,7 0,82 0,86 
    Level 1 Level 2 
Parameter Mean SD CV% Mean SD CV% 
pH 7.165 0.005 0.08 7.656 0.003 0.04 
pO2 (mmHg) 65.1 3.12 4.79 146.5 6.00 4.10 
pCO2(mmHg) 63.8 1.57 2.5 19.6 0.40 2 
Hb (g/dL) 10.2 0.44 1.5 16.66 0.50 1.0 
Na+ (mmol/L) 120.0 0.46 0.4 160.0 0.53 0.3 
K+(mmol/L) 2.85 0.038 1.3 6.30 0.039 0.6 
iCa+2(mmol/L) 1.60 0.017 1.1 0.84 0.012 1.4 
Glucose (mg/dL) 41.8 0.68 1.6 289 2.4 0.8 
Table 3. Precision  for within-day  of RP500 system 
Table 4. The precision values of i-STAT 
In a study comparing the results of the 
reference method with i-STAT from patients 
undergoing cardiopulmonary bypass and 
patients in intensive care units, they reported a 
significant difference for pO2 values (Stotler BA, 
Kratz A. 2013). In another study researchers 
found that the mean biases of pO2 were 
statistically significant (Steinfelder-Visscher J et 
al 2008). In our study we did not find any 
difference in terms of pO2 values but significant 
difference was found for pCO2, Hb, Na
+, iCa2+ 
and glucose parameters according to desirable 
mean, based on the acceptable bias data from 
OneWorld Accuracy External Quality program 
(Table 1). 
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Table  5. Comparison of results obtained from  
i-STAT  device within the Clin.Low and Clin.Up 
calculated based on TEA% of reference RP500  
TEA: Total allowable error.(11)Based on 
theseTEAClin.Low: lower limit of   clinically 
insignificant difference and  Clin.Up: upper  
limit of  clinically insignificant difference were 
calculated.  
 
Hb levels in i-STAT calculated via Hct 
measured by the conductometry system. Hct 
analysis has been shown in many studies that 
it methodically led to interference (Stott RA et 
al. 1995). The low protein concentration leads 
to low Hb values due to the significant 
negative bias in Hct measurement. Also, the 
reduction of the total conductivity in the 
electrolytes and colloid-containing infusions 
affects the result (Stott RA et al. 1995).  
We observed a quite high mean 
difference in calculated  Hb(%14)between the i
-STAT and the Rapid Point 500 analyzer 
(Table 1).In case of measuring Hb levels lower 
than real levels may cause unnecessary 
intraoperative blood transfusion and a volume 
overload which can result with serious 
complications such as intraoperative cardiac 
insufficiency, hemodynamic instability. And in 
case of measuring it higher than normal levels 
and deficient blood transfusion would result 
with inadequate tissue oxygenation. 
In the study comparing three different 
blood gas analyzers (EPoC, RL1265, and  
RP500) they found the significant mean 
difference in Hb values measured with the 
three analyzers, similar to the results of our 
study (Luukkonen AA et al. 2015). Also, 
abnormal electrolyte levels may cause 
incorrect Hb results as shown in the study 
used samples from patients undergoing 
CABG. They found a decrease in the 
conductivity of samples of these patients and 
they suggest that the decrease could affect the 
conductometric measurement of Hb 
(Steinfelder-Vischer J, 2008). The variation of 
Hb results of our study could be derived from 
the altered conductivity of the samples of 
patients undergoing CABG. 
One of the most affected parameters of 
preanalytical factors (such as air 
contamination, low volume or drug use 
(propofol, thiopental sodium) is pCO2. The 
significant difference of pCO2 values could be 
attributed to the fact that it is easily affected by 
preanalytical errors. 
In a study, they found that all 
parameters except lactate, Hb, Na+, and pCO2 
were within acceptable limits according to TEa 
(Luukkonen AA et al. 2015). Similarly, in our 
study, all parameters, except Hb and iCa2+ 
were found to be within the indicated limits 
according to TEa. 
 One of the limitations of our study was 
our results can be only limited to a particular 
patient group. Also, studies with larger sample 
groups could provide more information as we 
had a smaller sample group size. 
  
CONCLUSION 
 In conclusion, according to our results, 
there was a good correlation between the i-
STAT analyzer with the RP500 analyzer, 
except Hb and Na+. Also, all parameters 
except for Hb and ionized calcium were found 
to be within acceptable range regarding clinical 
decision limits. It is essential that the point-of-
care devices give accurate results as well as 
quick results. For this reason, we think that the 
point of care devices should be subject to 
external and internal quality control programs, 
users should train regularly, and feedback 
studies should be doing.  
  TEA, % 
RP500 
Clin.Low-
Clin.Up 
i-STAT 
pH - 
7,45 
- 
7,44 
p02 (mmHg) - 
93,95 
- 
102,46 
pC02 (mmHg) ±5,7 
37,25 
35,13-39,37 
35,92 
Hb (g/dL) ±4,19 
10,93 
10,48-11,38 
12,48 
Na+ (mmol/L) ±0,73 
139,54 
138,53-140,55 
137,12 
K+ (mmol/L) ±5,61 
4,02 
3,8-4,24 
4,05 
iCa+2 (mmol/L) ±2 
1,12 
1,10-1,14 
1,09 
Glucose (mg/
dL) 
±5,5 
176,98 
167,25-186,71 
173,22 
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Figure1 :Bland-Altman plots for the comparison of RP500 and i-STATresults. The y-axis 
represents the difference between RP500 and the comparison method i-STAT  (RP500 – i-
STAT), and the x-axis represents the average of RP500 and i-STAT values. Horizontal line sare 
drawn at themean difference (blue), at the mean difference ±1.96 SD (95% confidence intervals) 
of the differences (green dotted line). 
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